Literature DB >> 21070089

Primary Epstein-Barr virus infection with neurological complications.

Erik Bathoorn1, Bart J M Vlaminckx, Sung Schoondermark-Stolk, Richard Donders, Marjon van der Meulen, Steven F T Thijsen.   

Abstract

Several case studies have reported on neurological complications caused by a primary Epstein-Barr virus (EBV) infection. We aimed to investigate the viral loads and the clinical and inflammatory characteristics of this disease entity. We evaluated all 84 cases in which the EBV polymerase chain reaction test (PCR) was requested on cerebrospinal fluid (CSF) for the period 2003-2008. Fourteen patients with proven neuroborreliosis served as the control group. Nine patients were diagnosed with a primary EBV infection and neurological symptoms (median age 36 y; 4 male). Viral DNA copies in CSF were detected by PCR in 7 of 9 patients. The presenting symptoms were meningeal signs, epileptic insults, polyradiculomyelitis, polyradiculitis, and/or sudden cognitive disorders. All EBV cases had a pleocytosis with significantly increased mononuclear leukocytes as compared to the neuroborreliosis group (median 99% interquartile range (96-100%) versus 90% (86-97%). In cases with a primary EBV infection, viral loads ranged from 43 to 3202 copies/ml in CSF and from 61 to 15,595 copies/ml in serum. Seventy-eight percent of the cases had a positive PCR on CSF. This study provides criteria for diagnosing neurological disease during primary EBV infection. Primary EBV infections in immune competent persons can cause a broad range of neurological symptoms, with lymphocytic and monocytic inflammation both in blood and CSF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070089     DOI: 10.3109/00365548.2010.531760

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Nonconvulsive status epilepticus complicating epstein-barr virus encephalitis in a child.

Authors:  Filippo Greco; Maria Donatella Cocuzza; Pierluigi Smilari; Giovanni Sorge; Lorenzo Pavone
Journal:  Case Rep Pediatr       Date:  2014-03-12

Review 2.  Infectious encephalitis: Management without etiological diagnosis 48hours after onset.

Authors:  P Fillatre; Y Crabol; P Morand; L Piroth; J Honnorat; J P Stahl; M Lecuit
Journal:  Med Mal Infect       Date:  2017-03-15       Impact factor: 2.152

Review 3.  Epstein-Barr Virus and Neurological Diseases.

Authors:  Nan Zhang; Yuxin Zuo; Liping Jiang; Yu Peng; Xu Huang; Lielian Zuo
Journal:  Front Mol Biosci       Date:  2022-01-10

4.  Primary Epstein-Barr virus infection with polyradiculitis: a case report.

Authors:  Tilmann Hottenrott; Sebastian Rauer; Jochen Bäuerle
Journal:  BMC Neurol       Date:  2013-07-23       Impact factor: 2.474

5.  Epstein-Barr Virus Encephalitis in an Immunocompetent Child: A Case Report and Management of Epstein-Barr Virus Encephalitis.

Authors:  Gulsen Akkoc; Eda Kepenekli Kadayifci; Ayse Karaaslan; Serkan Atici; Nurhayat Yakut; Sevliya Ocal Demir; Ahmet Soysal; Mustafa Bakir
Journal:  Case Rep Infect Dis       Date:  2016-04-26

6.  Relapsing EBV encephalitis in a renal transplant recipient.

Authors:  Joshua A Stone; Bettina M Knoll; Dimitrios Farmakiotis
Journal:  IDCases       Date:  2017-09-28

7.  Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study.

Authors:  Luca Bartolini; Eleonora Piras; Kathryn Sullivan; Sean Gillen; Adrian Bumbut; Cheng-Te Major Lin; Emily C Leibovitch; Jennifer S Graves; Emmanuelle L Waubant; James M Chamberlain; William D Gaillard; Steven Jacobson
Journal:  Front Neurol       Date:  2018-10-05       Impact factor: 4.003

8.  Intracranial Epstein-Barr virus infection appearing as an unusual case of meningitis in an immunocompetent woman: a case report.

Authors:  Yue Wang; Qian Dong; Yu-Dan Chen; Wen-Li Hu; Li Zhao
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

9.  Comparison of clinical characteristics of a patient with Epstein-Barr virus-associated seizure and patients with COVID-19-associated seizure.

Authors:  Larry Nichols; Merritt Thompson; Gretchen L Bentz
Journal:  J Med Virol       Date:  2021-07-20       Impact factor: 20.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.